Hepion Pharmaceuticals, Inc. (HEPA) Free cash flow 2016–2024
Hepion Pharmaceuticals, Inc. (HEPA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$18.2MFY2024 · since FY2016: -$19.2M → -$18.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$18.2M | +55.4% |
| FY2023 | -$40.9M | -16.6% |
| FY2022 | -$35.1M | -12.1% |
| FY2021 | -$31.3M | -93.1% |
| FY2020 | -$16.2M | — |
| FY2016 | -$19.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More HEPA financial trends
HEPA RevenueHEPA Net incomeHEPA Net marginHEPA Gross profitHEPA Gross marginHEPA Operating incomeHEPA Operating marginHEPA Operating cash flowHEPA Capital expendituresHEPA Return on equityHEPA Stock buybacksHEPA Dividends paidHEPA Total assetsHEPA Total liabilitiesHEPA Shareholders’ equityHEPA overview →